U.S. Markets closed

HemaCare Corporation (HEMA)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.94+0.04 (+1.38%)
At close: 1:27PM EDT
People also watch
HMGNCVASLCARCNCTEMIS
Interactive chart
Previous Close2.90
Open2.94
Bid0.00 x
Ask0.00 x
Day's Range2.94 - 2.94
52 Week Range0.58 - 3.00
Volume1,978
Avg. Volume9,607
Market Cap30.38M
Beta0.75
PE Ratio (TTM)40.27
EPS (TTM)0.07
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • HemaCare Corp. :HEMA-US: Earnings Analysis: 2016 By the Numbers : May 4, 2017
    Capital Cube23 days ago

    HemaCare Corp. :HEMA-US: Earnings Analysis: 2016 By the Numbers : May 4, 2017

    Categories: Yahoo FinanceGet free summary analysis HemaCare Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of HemaCare Corp. – Tivity Health, Inc. (TVTY-US) that have also reported for this period. Highlights Gross margins widened from 45.45% to 51.35% compared to the same period last year, ... Read more (Read more...)

  • Business Wirelast month

    HemaCare Will Attend International Society of Cell Therapy in London

    HemaCare Corporation , a leader in cell and tissue collection, processing and cell therapy solutions, will be exhibiting at the annual meeting of the International Society of Cell Therapy in London, UK, May 3-6, 2017.

  • Business Wire2 months ago

    HemaCare Attends the American Association of Cancer Research Annual Meeting

    HemaCare Corporation , a leader in cell and tissue collection, processing and solutions for cell therapy, will be attending the AACR annual meeting at the Walter E. Washington Convention Center in Washington, D.C.